Loading...
Pharmaceutical Approval Update
Elotuzumab (Empliciti) and ixazomib (Ninlaro) for some multiple myeloma patients; Fluad (influenza vaccine, adjuvanted) for immunization of persons 65 years of age and older; and osimertinib (Tagrisso) for certain non–small-cell lung cancers
Saved in:
| Published in: | P T |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MediMedia USA, Inc.
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4699482/ https://ncbi.nlm.nih.gov/pubmed/26766887 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|